Search - tctmd.com

Displaying 81 - 100 of 750

Sort: Relevancy | Date

News Daily News

Misleading Statements Common in Online Ads for Compounded GLP-1s

L.A. McKeown

January 20, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis

L.A. McKeown

January 14, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Todd Neale

January 09, 2025

News Daily News

Aircraft Noise Exposure Linked to ‘Thicker, Weaker, and Stiffer Hearts’

Yael L. Maxwell

January 09, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Daily News

Top Policy and Practice News of 2024

Yael L. Maxwell

December 25, 2024

News Daily News

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

L.A. McKeown

December 23, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

L.A. McKeown

December 18, 2024

News Daily News

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

Yael L. Maxwell

December 17, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

L.A. McKeown

December 09, 2024

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Daily News

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Todd Neale

November 28, 2024

Advertisement

Misleading Statements Common in Online Ads for Compounded GLP-1s

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Aircraft Noise Exposure Linked to ‘Thicker, Weaker, and Stiffer Hearts’

Top Heart Failure News of 2024

TCTMD’s Top 10 Most Popular Stories for December 2024

Top General Cardiology and Prevention News of 2024

Top Policy and Practice News of 2024

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

December 2024 Dispatch for the CV Team

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

TCTMD’s Top 10 Most Popular Stories for November 2024

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content